Ziprasidone in the Psychosis Prodrome

Clinical trial NCT00635700 · COMPLETED

Trial details

NCT number: NCT00635700
Sponsor: Yale University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Psychosis Prodrome

Start date: 2008-03-01
Primary completion: 2012-11-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.